Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.14
Bid: 0.13
Ask: 0.15
Change: 0.00 (0.00%)
Spread: 0.02 (15.385%)
Open: 0.14
High: 0.14
Low: 0.135
Prev. Close: 0.14
GUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

1 Apr 2015 15:08

RNS Number : 2158J
Evocutis PLC
01 April 2015
 

 

 

1 April 2015

 

Evocutis plc

("Evocutis", or "the Company")

Interim Results for the six months ended 31 January 2015

Chairman's Statement

Introduction

We are pleased to report the interim results for the six months ended 31 January 2015.

This has been a period of considerable change for the Company. Following the general meeting on 12 September 2014, the directors who previously managed the trading operations of the Company stepped down from the board and Donald Strang, Hamish Harris and I were appointed to take responsibility for the future direction of the Company.

On 12 September 2014, shareholders approved a capital reorganisation, resulting in each of the Company's existing ordinary shares being subdivided into one new Ordinary Share of 0.01p and one Deferred Share of 0.99p.

Additionally, on 15 September 2014, the Company issued 175,000,000 new Ordinary Shares for 0.12p each for cash consideration of £210,000 (before expenses).

On the same date, the Company adopted a new Investing Policy under AIM Rule 15 and there were a number of board changes.

On 8 December 2014, the Company issued 375,000,000 new Ordinary Shares for 0.4p each for cash consideration of £1,500,000 (before expenses). Each new Ordinary Share carried a warrant which entitled the holder to subscribe for a further one new Ordinary Share in the Company at 0.4 pence per share up to 31 December 2015.

On 18 December 2014, the Company announced that it had signed a Binding Term Sheet ("BTS") to acquire an initial 10% interest in Brazil Tungsten Holdings Limited ("BTHL") which owns a 25 year lease over (with the option to extend) the producing Bodó Tungsten Mine ("Bodó") in Rio Grande do Norte, Brazil, by investing US$1 million in new capital in BTHL for the specific purposes of mine expansion.

On 12 February 2015, the Company announced that final contracts had been signed completing the acquisition of the initial 10% interest of BTHL. The Company also has an exclusive option to increase its holding in BTHL to 20% within 60 days by investing a further US$1 million towards mine expansion, subject to certain conditions to be advised. This expires on 11 April 2015.

On 19 March 2015, the Company announced that it had made the following further investments:

- A 2% interest (being 20 shares) in Horse Hill Developments Ltd ("HHDL"), the 65% owners and operators of onshore exploration licences PEDL 137 and PEDL 246 (known as "Horse Hill"). The additional 2% interest was acquired for a consideration of £425,000;

 

- A 3.01% interest (being 29.2 million shares) in Noricum Gold Limited which is a UK AIM listed company whose main interest is their 100% owned Schonberg Gold and Precious Metals project in Austria. This investment was acquired on market for a cost of £61,205;

 

- A 3.13% interest (being 55 million shares) in Alba Mineral Resources Plc, a UK AIM listed company who holds interests in Ireland (base metals); England (oil and gas) and other countries. This investment was acquired via a recent share placement for a cost of £55,000.

Having made all of the above investments, the Company has substantially implemented its Investing Policy in accordance with Rule 15 of the AIM Rules for Companies.

Outlook

The Board considers that the current Investing Policy is in the best interests of the Company and its Shareholders as a whole.

The Company has acquired four investments during the period, which we believe will enhance future shareholder value.

The Directors regularly assess investment opportunities for the Company in accordance with the Investing Policy and we are committed to our investments made to date. Capital raised as noted above by the Company puts it in a good position to pursue further investment opportunities from time to time.

The Board acknowledges this exciting period for the Company as it continues to evaluate and seek additional investments as opportunities arise.

The Board would like to take this opportunity to thank our shareholders for their continued support and I look forward to reporting further progress over the next period and beyond.

 

 

David Lenigas

Chairman

 

1 April 2014

 

For further information, please contact:

 

Evocutis Plc

David Lenigas/Donald Strang

+44 (0) 20 7440 0640

 

Cairn Financial Advisers LLP

James Caithie/Carolyn Sansom

+44 (0) 20 7148 7900

 

 

 

 

The interim results will be available electronically on the Group's website: www.evocutis.com.

 

Evocutis plc

Interim statement of comprehensive income - unaudited

For the six months ended 31 January 2015

UnauditedSix months ended31 January 2015

UnauditedSix months ended31 January 2014

AuditedYear ended31 July 2014

£'000

£'000

£'000

Continuing operations

Administrative costs

(57)

(69)

(127)

Finance income

-

2

2

Revaluation of available for sale asset

-

-

(72)

Loss before tax

(57)

(67)

(197)

Taxation

-

-

-

Loss for the period from continuing operations

(57)

(67)

(197)

Discontinued operations

Loss for the period from discontinued operations

(5)

(355)

(506)

Loss for the period and total comprehensive loss attributable to equity shareholders

(62)

(422)

(703)

Loss per ordinary share

Basic and diluted - continuing operations

(0.01p)

(0.04p)

(0.11p)

Basic and diluted - discontinued operations

(0.00p)

(0.20p)

(0.29p)

Evocutis plc

Interim statement of financial position - unaudited

As at 31 January 2015

UnauditedAt 31 January 2015

UnauditedAt 31 January 2014

AuditedAt 31 July 2014

£'000

£'000

£'000

ASSETS

Non-current assets

Intangible assets

164

-

-

Available for sale investments

138

-

138

302

-

138

Current assets

Trade and other receivables

308

62

15

Current tax recoverable

-

95

-

Cash and cash equivalents

1,277

304

124

1,585

461

139

Non-current assets classified as held for sale

-

212

-

1,585

673

139

Total assets

1,887

673

277

LIABILITIES

Current liabilities

Trade and other payables

(73)

(131)

(21)

(73)

(131)

(21)

Non-current liabilities

Deferred tax liabilities

-

(5)

-

-

(5)

-

Total liabilities

(73)

(136)

(21)

Net assets

1,814

4537

256

EQUITY

Equity attributable to equity holders of the company

Called up share capital

1,802

1,747

1,747

Share premium reserve

9,199

7,634

7,634

Merger reserve

-

641

-

Share-based payments reserve

114

143

114

Retained earnings

(9,301)

(9,628)

(9,239)

Total equity

1,814

537

256

Evocutis plc

Interim statement of changes in equity - unaudited

For the six months ended 31 January 2015

Share Capital

Share Premium

Merger Reserve

Share Based Payment Reserve

Losses

Total

£'000

£'000

£'000

£'000

£'000

£'000

Unaudited

At 1 August 2013

1,747

7,634

641

138

(9,206)

954

Loss for the six month period ended 31 January 2015

-

-

-

-

(422)

(422)

Total comprehensive loss

-

-

-

-

(422)

(422)

Transactions with owners:

Share option charge in the period

-

-

-

5

-

5

At 31 January 2014

1,747

7,634

641

143

(9,628)

537

Audited

At 1 August 2013

1,747

7,634

641

138

(9,206)

954

Loss for the year ended 31 July 204

-

-

-

-

(703)

(703)

Transfers

-

-

(641)

-

641

-

Total comprehensive loss

-

-

(641)

-

(62)

(703)

Transactions with owners:

Shares options lapsed

-

-

-

(29)

29

-

Share option charge in the year

-

-

-

5

-

5

At 31 July 2014

1,747

7,634

-

114

(9,239)

256

Unaudited

At 1 August 2014

1,747

7,634

-

114

(9,239)

256

Loss for the six month period ended 31 January 2015

-

-

-

-

(62)

(62)

Total comprehensive loss

-

-

-

-

(62)

(62)

Share issue

55

1,655

-

-

-

1,710

Cost of share issue

-

(90)

-

-

-

(90)

At 31 January 2015

1,802

9,199

-

114

(9,301)

1,814

Evocutis plc

Interim statement of cash flows - unaudited

For the six months ended 31 January 2015

UnauditedSix months ended31 January 2015

UnauditedSix months ended31 January 2014

AuditedYear ended31 July 2014

£'000

£'000

£'000

Cash flows from operating activities

Loss after tax

(62)

(422)

(703)

Taxation

-

-

(4)

Finance income

-

(2)

(2)

Depreciation

-

16

16

Amortisation of intangible assets

-

14

14

Profit on disposal of property, plant and equipment

-

(2)

(5)

Revaluation of AFS Impairment losses

-

-

72

Share-based payment charges

-

5

5

Operating cash outflow before changes in working capital

(62)

(391)

(607)

Movement in trade and other receivables

(293)

80

127

Movement in trade and other payables

52

(75)

(185)

Cash flow from operations

(303)

(387)

(665)

Tax received

-

-

94

Net cash flows used in operating activities

(303)

(387)

(571)

Cash flow from investing activities

Payments to acquire intangible assets

(164)

-

-

Purchase of property, plant and equipment

-

-

(1)

Disposals of property, plant and equipment

-

25

30

Finance income

-

1

2

Net cash outflow from investing activities

(164)

26

31

Cash flows from financing activities

Proceeds on issuing of ordinary shares

1,710

-

-

Cost of issue of ordinary shares

(90)

-

-

Net cash inflow from financing activities

1,620

-

-

Net decrease in cash and cash equivalents

1,153

(360)

(540)

Cash and cash equivalents at start of period

124

664

664

Cash and cash equivalents at end of period

1,277

304

124

Notes to the interim report

For the six months ended 31 January 2015

1 Basis of preparation

As permitted IAS 34, 'Interim Financial Reporting' has not been applied to these half-yearly results. The financial information of the Company for the six months ended 31 January 2015 have been prepared in accordance with the recognition and measurement principles of International Financial Reporting Standards, International Accounting Standards and Interpretations (collectively "IFRS") issued by the International Accounting Standards Board ("IASB") as adopted by the European Union ("adopted IFRS") and are in accordance with IFRS as issued by the IASB. The condensed interim financial information has been prepared using the accounting policies which will be applied in the Company's statutory financial statements for the year ending 31 July 2015.

The financial information shown in this publication is unaudited and does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The comparative figures for the financial year ended 31 July 2014 have been derived from the statutory accounts for 2014. The statutory accounts have been delivered to the Registrar of Companies. The auditors have reported on those accounts; their report was unqualified and did not contain statements under the section 498(2) or 498(3) of the Companies Act 2006.

 

2 Loss per share

The calculation of the loss per share is based on the loss attributable to ordinary shareholders divided by the weighted average number of shares in issue during the period.

UnauditedSix months ended31 January 2015

UnauditedSix months ended31 January 2014

AuditedYear ended31 July 2014

£'000

£'000

£'000

Loss on continuing activities

(57)

(67)

(197)

Loss on discontinuing activities

(5)

(355)

(506)

Loss on ordinary activities after tax

(62)

(422)

(703)

Weighted average number of shares for calculating basic loss per share

415,980,348

174,676,000

174,676,000

Basic and diluted - continuing activities

(0.01)

(0.04)

(0.11)

Basic and diluted - discontinued activities

(0.00)

(0.20)

(0.29)

Basic and diluted loss per share (pence)

(0.01)

(0.24)

(0.40)

However, due to losses incurred in the year there is no dilutive effect from the potential exercise of the share options in existence.

3 Post balance sheet events

On 12 February 2015, the Company announced that final contracts had been signed that completes the acquisition of the initial 10% interest of the Bodó Tungsten Mine ("Bodó") in Brazil.

On 19 March 2015, the Company announced that it has acquired the following further investments:

• A 2% interest (being 20 shares) in Horse Hill Developments Ltd ("HHDL"), the 65% owners and operators of onshore exploration licences PEDL 137 and PEDL 246 (known as "Horse Hill"). The additional 2% interest was acquired for a consideration of £425,000;

• A 3.01% interest (being 29.2 million shares) in Noricum Gold Limited which is a UK AIM listed company whose main interest is their 100% owned Schonberg Gold and Precious Metals project in Austria. This investment was acquired on market for a cost of £61,205;

• A 3.13% interest (being 55 million shares) in Alba Mineral Resources Plc, a UK AIM listed company who holds interests in Ireland (base metals); England (oil and gas) and other countries. This investment was acquired via a recent share placement for a cost of £55,000.

Having made all of the above investments, the Company has substantially implemented its Investing Policy in accordance with Rule 15 of the AIM Rules for Companies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR GMGGDDMDGKZM
Date   Source Headline
6th Dec 20129:57 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20127:00 amRNSApproval of Opening Position Disclosure
5th Dec 201211:11 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 201211:53 amRNSForm 8.5 (EPT/NON-RI)
3rd Dec 201212:19 pmRNSForm 8.3 - [Evocutis PLC]
3rd Dec 20127:00 amRNSStrategic Review
3rd Dec 20127:00 amRNSFinal Results
23rd Nov 20127:00 amRNSNotice of Results
5th Nov 20127:00 amRNSIssue of Equity
21st Sep 20127:00 amRNSTR-1 Notification of Major Interest in Shares
8th Aug 201212:24 pmRNSUpdate on commencement of dealings
1st Aug 20127:00 amRNSIssue of Equity and Grant of Share Options
21st Jun 20127:00 amRNSTrading Update
30th Apr 20127:00 amRNSDirectorate Change
4th Apr 20127:00 amRNSDirectorate Change
22nd Mar 20127:00 amRNSInterim Results
29th Feb 20127:00 amRNSNotification of Results
27th Jan 20127:00 amRNSEvocutis validates anti-ageing LabSkinT model
24th Jan 20121:35 pmRNSResult of AGM
13th Jan 20127:00 amRNSEvocutis Opens State-of-the-art laboratory
23rd Dec 20117:00 amRNSDirector/PDMR Shareholding
15th Dec 20117:00 amRNSNotice of AGM and Report and Accounts
29th Nov 20117:00 amRNSPreliminary Results
28th Nov 20117:00 amRNSEvocutis launches antimicrobial LabSkinT model
20th Oct 20115:03 pmRNSResult of GM and Change of Name to Evocutis plc
30th Sep 20117:00 amRNSBusiness Update
27th Sep 20117:00 amRNSPosting of Circular and Notice of General Meeting
8th Jul 20117:00 amRNSChange of Registered Office
21st Jun 201111:00 amRNSDirectorate Change
23rd May 201111:45 amRNSResult of General Meeting
11th May 201111:17 amRNSDirector's Dealing
6th May 20117:00 amRNSAcquisition and Placing to raise £2 million
27th Apr 20112:30 pmRNSBusiness Update
8th Mar 20117:00 amRNSInterim Results
2nd Mar 20113:12 pmRNSHolding(s) in Company
25th Feb 20117:00 amRNSHolding(s) in Company
20th Jan 20111:23 pmRNSResult of AGM
17th Jan 20117:00 amRNSSyntopix to research biofilms for Beiersdorf AG
14th Jan 201110:13 amRNSPosting of Annual Report and notice of AGM
3rd Dec 20107:00 amRNSGrant of share options to Directors
29th Nov 20107:00 amRNSFinal Results
11th Nov 20107:00 amRNSAppointment of Broker
1st Nov 20107:00 amRNSSecond Agreement with Sinclair Pharma
29th Sep 20105:05 pmRNSHolding(s) in Company
27th Sep 20102:51 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSAgreement with Global Consumer Products Company
22nd Jun 20103:20 pmRNSDirectorate Change
22nd Apr 20107:00 amRNSAgreement with Sinclair Pharma plc
31st Mar 201011:25 amRNSResult of General Meeting
15th Mar 201011:08 amRNSProposed Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.